Amazon (AMZN) has been steadily expanding into healthcare, and now it’s setting its sights on telehealth companies like Hims ...

Shares of Hims & Hers ($HIMS) plummeted nearly 15% on Thursday after Amazon.com, Inc. ($AMZN) launched its new Amazon One ...

One Medical telehealth service is adding a new option that will put it in direct competition with digital health company ...

Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile disfunction and ...

Amazon One Medical is expanding its telehealth services with the launch of treatment plans and medication delivery for ...

Shares of Hims&Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

(Irwin, 11/13) Yahoo Finance: Hims & Hers Launches GLP-1 Tracker In Response To FDA's Shortage Decision Hims & Hers is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s ...

"Full House" actor Dave Coulier, 65, revealed he has stage 3 non-Hodgkin's lymphoma. ( People) The latest tally of the ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new ...

Hims & Hers (HIMS) fell 17% Thursday after Amazon (AMZN) announced it was launching an expanded pay-per-visit telehealth ...